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Introduction
Sydenham’s chorea is an enigmatic
manifestation of rheumatic fever. Although
Sydenham’s chorea is rare in developed countries,
we have observed an increase in its frequency in
our country during the last few years.1
It may appear as an isolated manifestation
of rheumatic fever or precede or accompany
an acute attack associated with other criteria
of the disease.2-5
The relationship between Sydenham’s
chorea and rheumatic fever has been the
subject of considerable controversy and some
aspects continue to be intriguing. Since chorea
is generally a late manifestation, it is unusual
to find clinical or even immunological
(laboratory) evidence of a streptococcal
infection, and the erythrocyte sedimentation
rate is usually normal.6
In 1985, Berrios et al.7 reported that 32%
of their Sydenham’s chorea patients suffered a
recurrence despite the penicillin prophylaxis,
which raised doubts not only about the
relationship with the streptococci but also, in
some cases, about the rheumatic fever itself.
We had also observed that some of our patients
presented recurrence of chorea despite regular
treatment with benzathine penicillin. Our aim
was to study the clinical and evolutive
characteristics of Sydenham’s chorea patients
and the frequency of the recurrences, as well
as the relationship with regular prophylaxis.
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Methods
A retrospective evaluation of the records
of 290 rheumatic fever patients diagnosed
according to the revised Jones criteria (1992)8
was carried out between 1986 and 1999.
Patients diagnosed before 1992 were
reevaluated to ascertain whether they fulfilled
the 1992 Jones criteria.
Children of less than 16 years of age, with
well-established chorea and a follow-up period
equal to or greater than one year were included
in the study. Patients with a family history of
chorea, or positive antinuclear antibody, were
excluded.
The epidemiological data, the clinical
characteristics of the attacks (initial and
recurrent) and the compliance with secondary
prophylaxis (every 21 days) were analyzed. We
defined recurrence as when the patient
presented manifestations of chorea after a
minimum period of 4 months without
symptoms and medication.
The anti-streptolysin O titer had been
measured in the majority of patients. It was
considered altered when there was an increase
of two or more titer steps in relation to the
previous titer (15-day interval) or when one
titer was equal to or greater than 800 IU/ml
(in cases with only one measurement).
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Results
Of the 290 patients with rheumatic fever,
86 (29.6%) had chorea during the first attack
of the disease. There were a total of 100
chorea episodes, including recurrences. Fifty-
five patients with Sydenham’s chorea were
female (ratio 1.7:1) and 44 non-Caucasian.
The mean age at onset of symptoms was 9.7
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CONTEXT: During the last 12 years we have observed
an increase in the frequency of Sydenham’s chorea
in our country. We have observed that some of our
patients have presented recurrence of the chorea
despite regular treatment with benzathine penicillin.
OBJECTIVE: The aim of our study was to evaluate
clinical and evolutive characteristics of Sydenham’s
chorea in a group of patients followed in our
Pediatric Rheumatology Unit.
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SETTING: Section of Pediatric Rheumatology - Discipline
of Allergy, Clinical Immunology and Rheumatology
- Department of Pediatrics - UNIFESP - EPM.
PARTICIPANTS: Two hundred and ninety patients with
rheumatic fever followed between 1986 and 1999.
METHODS: We reviewed the records of 290 patients
with rheumatic fever followed between 1986 and
1999. All patients were diagnosed according to
the revised Jones criteria (1992). We included 86
patients that presented Sydenham’s chorea as one
of the major criteria (one or more attacks) and
evaluated their clinical and evolutive characteristics
as well the treatment.
RESULTS: Fifty-five patients were girls and 31 were boys.
The mean age at onset was 9.7 years and mean
follow-up period was 3.6 years. The 86 Sydenham’s
chorea patients presented 110 attacks of chorea.
We observed isolated chorea in 35% of the patients,
and 25 (29%) presented one or more recurrences.
We included only 17 of the 25 patients for further
analysis, with a total of 22 recurrences of which 14
were attacks of chorea, because it was not possible
to precisely detect the interval between attacks in
the other patients. The approximate interval between
the attacks ranged from 4 to 96 months. In 71% of
the patients there was no failure in the secondary
prophylaxis with benzathine penicillin, which was
performed every 3 weeks.
CONCLUSION: Despite the regular use of secondary
benzathine penicillin prophylaxis, children with
rheumatic fever have a high risk of Sydenham’s
chorea recurrence.
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years old and the mean follow-up period was
3.6 years (Table 1).
Sydenham’s chorea occurred in isolation
in 30 patients (35%) and in association with
other symptoms in 56 patients (65%), during
the first episode of rheumatic fever. In the
latter we observed chorea (co) and carditis (ca)
in 38 patients, chorea, carditis and arthritis
(ar) in 14 and chorea and arthritis in 4 patients.
Of the 86 patients who presented chorea at
the first attack, 25 (29%) had 32 recurrences,
of which 24 were of chorea. These recurrences
began after a minimum of 4 months without
symptoms and without specific chorea
treatment. In 8 patients (10 episodes), it was
not possible to precisely detect the interval
between attacks and for this reason, these were
not included in the study.
We therefore included only 17 of the 25
patients for further analysis, with a total of 22
recurrences of which 14 were attacks of chorea.
Within this group, 10 patients were female and
9 were Caucasian. The mean age at onset was
9.8 years old and the mean follow-up period
4.8 years (Table 1). The manifestations of the
recurrent attacks are described in Table 2.
Of the 30 patients who presented with
isolated chorea at the first attack, 8 (26.6%)
had disease recurrence: 6 with chorea (5 in
isolation and 1 in association); 1 with carditis;
and 1 with carditis and arthritis. Of the 56
patients who presented with chorea associated
with another major disease manifestation
during the first attack, 9 (16%) had
recurrences. The intervals between the attacks
of chorea can also be found in Table 2.
According to the information from the
patient or parents, 61 children (71%) had no
failure in the secondary prophylaxis while 25
(29%) were not compliant.
Of the 17 patients who presented
recurrences, 9 (53%) showed good compliance.
Anti-streptolysin O was measured in 8 out
of 14 patients with disease recurrence and was
found to be normal in all of them.
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Discussion
Rheumatic fever is still a prevalent disease
in our country and an important cause of
morbidity due to chronic cardiopathy.9
Sydenham’s chorea was described by
Thomas Sydenham in 1686 and it has been
associated with rheumatic fever since 1956.10
It is a major manifestation of rheumatic fever
and, according to the latest modification of
the Jones criteria in 1992, a criterion sufficient
even by itself for the diagnosis of the disease.8
The incidence of Sydenham’s chorea has been
increasing in our country over the last few
years, as demonstrated in a recent publication.1
In a study undertaken in 7 centers in the State
of São Paulo (Brazil) with 786 patients, chorea
was present in 38% of rheumatic fever patients
(299 patients).11
In our study, Sydenham’s chorea occurred
in 30% of our 290 patients (86 patients),
which is similar to the frequency found by
Cardoso et al,12 but higher than the frequency
reported in the majority of the studies.8,13
Interestingly, of the 86 patients who presented
with chorea at the first attack, approximately
60% had carditis in association with it.
However, we did not observe a predominance
of isolated chorea, as described in the
literature14. We speculate that this fact may
be related to the referral practice among our
patients, where some of them, especially those
Sao Paulo Med J/Rev Paul Med 2002;120(1):16-9.
with isolated chorea, are followed up by other
specialists. Additional studies are necessary to
confirm whether this fact may also be related
to specific characteristics of our patient
population or even to the streptococcal strains
involved.
Nevertheless, of the 22 recurrences, only
3 (13.6%) presented isolated or associated
carditis. Thus, we did not detect a higher
probability of recurrences with cardiac
involvement in patients who presented chorea
at the first attack, as described in the
literature.15
 
Cardoso et al. have suggested that
carditis could be related to longer duration
for Sydenham’s chorea.16
Overall, 17 children (19.7%) presented
with recurrences; of these, 9 used regular
prophylaxis and 8 were non-compliant. Since
we were unable to determine serum levels of
penicillin in these patients, compliance was
Table 1. Patients with Sydenham’s chorea in the first attack and recurrences,
according the gender, race, age at onset and follow-up period
Chorea N Gender Race Age at onset - Follow-up period -
(F:M) (C:NC) years (mean) years (mean)
First attack 86 55:31 42:44 9.7 3.6
1.7:1
Recurrence 17 10:7  9:8 9.8 4.8
1.4:1
F: Female  C: Caucasian
M: Male  NC: Non-Caucasian.
Table 2. Age and clinical characteristics of Rheumatic Fever patients with Sydenham’s
chorea at the first attack and recurrences presented (n = 17)
1st attack 1st recurrence 2nd recurrence 3rd recurrence
Patient Age Jones Age Jones Age Jones Age Jones
Gender (years) Major (years) Major (years) Major (years) Major
Criteria Criteria Criteria Criteria
1 Fem. 12 co 13 co+ar 14.5 ar
2 Male 4 co 4.7 co
3 Fem. 12.6 co 13 co
4 Fem. 11.9 co 12.3 co 12.6 co
5 Fem. 6.9 co 7.2 co
6 Fem. 11.1 co 13.2 ca
7 Fem. 8.2 co 10.1 co
8 Male 11.7 co 14.1 ca+ar
9 Male 12.7 co+ca 13.1 co
10 Male 11 co+ca+ar 15 co+ar
11 Male 9.2 co+ar 9.9 ca+ar
12 Male 9.3 co+ca+ar 10.8 ar
13 Fem. 10.8 co+ca+ar 11.2 co 12.2 co
14 Fem. 10.1 co+ar 10.6 ar 13 ar 14.3 co+ar
15 Fem. 9.4 co+ca 13 ar
16 Fem. 7.6 co+ca+ar 15.6 co
17 Male 9 co+ca 14.5 co+ar
Fem. - female; co- chorea; ca- carditis; ar- arthritis.
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assessed according to the information from
patients and parents.
In 14 out of 22 recurrences, chorea was
present, either in isolation or in association
with another manifestation. We did observe a
predominance of chorea (63%) in the
recurrences, which proves the tendency of
chorea to mimic its first attack.17
Since we were intrigued by the high
frequency of recurrences in patients with
chorea who were on regular prophylaxis, we
would like to emphasize a few issues:
1. We believe that the recurrences, including
those in patients with a short interval (4
months) between the attacks, are not a
continuation of the same attack, since
those children remained asymptomatic
and did not receive any treatment for their
chorea during this period. It is important
to mention that there is no reference in
the literature regarding the minimum time
required between two attacks;
2. There is a possibility that a chorea attack
may be induced by non-streptococcal
stimuli other than those already known
(birth-control pills and pregnancy), which
could explain the recurrences in patients
receiving regular prophylaxis;
3. The efficacy of the antibiotics used in
secondary prophylaxis may be limited due
to the uncertain quality of some products;
4. Other non-rheumatic causes of chorea,
such as viral infections, tumors of the
central nervous system, degenerative
processes, among others,18-21 have to be
considered. This is especially so for those
patients who present with recurrent isolated
chorea while on adequate prophylaxis.
There is a lack of clinical and laboratory
evidence for prior streptococcal infection and
a lack of elevation of acute-phase proteins in
the great majority of Sydenham’s chorea
patients. This leads us to believe that pure
chorea is a “special” manifestation of
rheumatic fever or that, in some cases, it may
be related to another diagnosis. In some
individuals, the recurrence of rheumatic fever
is caused by light or transient streptococcal
infections that may remain undetected in
culturing or immunological tests.7 In this
study, we did not observe a significant increase
in anti-streptolysin O titers in any patient.
Kulkarni et al. described a 21% relapse rate
in cases of Sydenham’s chorea. However, data
on the clinical characteristics of the patients or
their prophylaxis compliance are lacking.14
In the opinion of Berrios et al., some of
these chorea episodes do not represent distinct
attacks but exacerbations in patients who have
chronic and persistent choreic activity,
characterizing the natural course of the
disease.7 We believe, however, that after a
minimum period of 4 months without clinical
manifestations or specific treatment, the
recurrence of choreic movements represents a
clinical relapse rather than an ongoing disease.
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CONCLUSION
Despite the regular use of secondary
benzathine penicillin prophylaxis, children
with rheumatic fever are at a high risk for the
recurrence of Sydenham’s chorea.
Since the relationship of chorea and its
recurrences to other clinical manifestations of
rheumatic fever is poorly understood, rigorous
prophylaxis with penicillin and periodic
follow-up are necessary.
Sao Paulo Med J/Rev Paul Med 2002;120(1):16-9.
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CONTEXTO: Observamos um aumento na
freqüência de coréia de Sydenham no nosso
meio durante os últimos 12 anos. Foi
verificado que alguns pacientes apresentaram
recorrência da coréia apesar da profilaxia
regular com penicilina benzatina.
OBJETIVO: Avaliar as características clínicas e
evolutivas da coréia de Sydenham em um
grupo de pacientes acompanhados no nosso
ambulatório de Reumatologia Pediátrica.
TIPO DE ESTUDO: Estudo retrospectivo.
LOCAL: Setor de Reumatologia Pediátrica,
Disciplina de Alergia, Imunologia clínica e
Reumatologia, Departamento de Pediatria,
Universidade Federal de São Paulo/Escola
Paulista de Medicina.
PARTICIPANTES: 290 pacientes com febre
reumática seguidos no período de 1986 e 1999.
MÉTODOS: Revisamos os prontuários de 290
pacientes com febre reumática seguidos no
período de 1986 a 1999. Todos os pacientes
tiveram o diagnóstico de febre reumática de
acordo com os critérios de Jones revisados
(1992). Foram incluídos 86 pacientes que
apresentaram coréia de Sydenham como
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
RESUMO
manifestação maior (um ou mais surtos) e
avaliamos suas características clínicas e
evolutivas bem como tratamento.
RESULTADOS: 55 pacientes eram do sexo
feminino e 31 do masculino. A idade média
de início da doença foi 9,7 anos e o tempo
médio de evolução 3,6 anos. Os 86 pacientes
com coréia de Sydenham apresentaram 110
surtos de coréia. Nós observamos coréia isolada
em 35% dos pacientes e 25 (29%)
apresentaram uma ou mais recorrências. Foram
incluídos para o estudo apenas 17 de 25
pacientes com 22 recorrências e 14 surtos de
coréia, pois não foi possível detectar o intervalo
entre os surtos nos outros pacientes. O
intervalo entre os surtos variou de quatro a 96
meses. Em 71% dos pacientes não ocorreu
falha na profilaxia secundária com penicilina,
que foi realizada a cada três semanas.
CONCLUSÃO: Apesar do uso regular de
profilaxia com penicilina benzatina, as
crianças com febre reumática têm um maior
risco de recorrência de coréia de Sydenham.
PALAVRAS-CHAVE: Febre reumática. Coréia de
Sydenham. Recorrência. Profilaxia.
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